| 标题 |
 Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
cdercder
Criminology34
张欢馨
ming2026
渡人舟
loii
斯文的白玉
LJJ019
MchemG
Kao
东方元语
GingerF
学术文献互助
emiya
heekkll
赵赶超
22336
端庄的寒梅
Colden
皖公网安备34019202002308
